Quantcast

Daily Archives: March 26, 2007

Pipeline400px

CombinatoRx, Maybe Not As Bad As It Looked

Posted: March 26, 2007 at 6:04 pm

CombinatoRx (CRXX) is still down in after-hours trading, but nowhere near the levels that it looked like the stock was trading at.  The stock was initially down more than 20% ...
Read Full Story »

Cramer Pick: Activist Investors & Underperforming Management

Posted: March 26, 2007 at 5:50 pm

Cramer also has a pick of underperforming management and activist activity.  This pick is PDL BioPharma (PDLI-NASDAQ).  The company gets royalties from Avastin and Herceptin from Genentech, but the company ...
Read Full Story »

PC Makers Off Suicide Watch As Vista Sales Rise?

Posted: March 26, 2007 at 5:33 pm

Microsoft (MSFT) has already sold 20 million copies of Vista. That is much faster than sales of Windows XP sales in it first month. The news is good for two ...
Read Full Story »

Cramer Names VF Corp to a Trusted CEO List

Posted: March 26, 2007 at 5:24 pm

Cramer said that he is also a cynical and skeptical man, but sometimes you need to trust people to make you many.  Some CEO's can make you more money if ...
Read Full Story »

Cramer’s Next Biosite Type Pick

Posted: March 26, 2007 at 5:13 pm

On CNBC's MAD MONEY tonight, Cramer showed where his Biosite (BSTE) that he recommended one month ago has been given a buyout and is up 50%.  But what he wants ...
Read Full Story »

Biotech Implosion: CombinatoRx (CRXX)

Posted: March 26, 2007 at 3:30 pm

If having a difficult to say and spell name wasn't bad enough, issuing poor study results will do it.CombinatoRx, Inc. (CRXX-NASDAQ) just announced preliminary results of a Phase II clinical ...
Read Full Story »

52-Week Low Club (MAR 26, 2007)

Posted: March 26, 2007 at 3:11 pm

Amgen (AMGN) $57.14 (-1.5%)As the FDA keeps talking up generic biotech drugs, Amgen is the first at risk.  It actually closed up 3% from the $57.11 low so it avoided ...
Read Full Story »

Two Less Followed Stent-Related Companies At Risk

Posted: March 26, 2007 at 2:09 pm

There are two companies that are not as frequently referred to in stent-land, and depending on how you interpret today's news that stents don't improve lives any better than dugs ...
Read Full Story »

Cramer Picks on Stop Trading (MAR 26, 2007)

Posted: March 26, 2007 at 1:46 pm

On CNBC's STOP TRADING segment, Cramer said that the looting at Tyco (TYC) was real and that is why "Big Koz" went to jail.Freeport-McMoRan (FCX) was a stock that was ...
Read Full Story »

Big 3 & Bush Make No Impact on Stocks

Posted: March 26, 2007 at 12:02 pm

President Bush today met again with the top executives of the US Auto Industry.  The common goals of "helping" the US auto industry is still a bit odd because the ...
Read Full Story »

Cramer on High Oil & Gold

Posted: March 26, 2007 at 11:39 am

In today's Wall Street Confidential video on TheStreet.com, Cramer said the standoff in Iran should keep oil prices higher.  The higher oil prices may reignite the earnings in the sector.  ...
Read Full Story »

Citigroup’s Chuck Prince Won’t Take a Hint

Posted: March 26, 2007 at 11:31 am

Citigroup (C-NYSE) needs to make it 15,001.  Chuck Prince told Reuters that he wouldn't comment on the reports of layoffs.  What is ironic here is that Citigroup is down today.  ...
Read Full Story »

Alcatel-Lucent Rises From The Grave

Posted: March 26, 2007 at 8:35 am

Last weak, Goldman Sachs said Alcatal-Lucent revenue was in "free fall" due to management's inability to properly manage the merger of the two telecom equiment markers. The ALU stock was ...
Read Full Story »

Boston Scientific Bad Hair Day: Stent Applications Narrow

Posted: March 26, 2007 at 8:26 am

A new, very large test, shows that bare-metal stents barely work in patients with chronic chest pain who have their heart disease managed with medicine.Boston Scientific needs stent use to ...
Read Full Story »

Pfizer Gets Bitten

Posted: March 26, 2007 at 8:18 am

Life does not get any easier for Pfizer (PFE). Forget generics. Now other drug firms are ganging up on them. Merck (MRK) and Schering-Plough are going to offer  drug that ...
Read Full Story »